Results 31 to 40 of about 4,894,740 (406)

COLOR III: a multicentre randomised clinical trial comparing transanal TME versus laparoscopic TME for mid and low rectal cancer [PDF]

, 2015
Total mesorectal excision (TME) is an essential component of surgical management of rectal cancer. Both open and laparoscopic TME have been proven to be oncologically safe.
Bonjer, HJ, De Lange-de Klerk, ES, Deijen, CL, Hanna, GB, Lacy, AM, Mavroveli, S, Sietses, C, Tsai, A, Tuynman, JB, Velthuis, S   +9 more
core   +1 more source

Relationship between hospital volume and short-term outcomes: A nationwide population-based study including 75,280 rectal cancer surgical procedures [PDF]

, 2018
There is growing interest on the potential relationship between hospital volume (HV) and outcomes as it might justify the centralization of care for rectal cancer surgery. From the National Italian Hospital Discharge Dataset, data on 75,280 rectal cancer
Barina, Andrea, Bergamo, Francesca, Boso, Caterina, Corti, Maria Chiara, Frambach, Patrick, Gennaro, Nicola, Marchegiani, Francesco, Maretto, Isacco, Perin, Alessandro, Pucciarelli, Salvatore, Rugge, Massimo, Urso, Emanuele Damiano Luca, Zorzi, Manuel, Zuin, Matteo   +13 more
core   +1 more source

Accuracy of High Resolution Multidetector Computed Tomography in the Local Staging of Rectal Cancer

Journal of Gastrointestinal and Abdominal Radiology, 2022
Background Magnetic resonance imaging (MRI) is the gold standard for local staging of rectal cancer. Advanced computed tomography (CT) machines are now capable of high-resolution images of rectal cancer and utilized for CT perfusion.
Rochita Venkata Ramanan, Venkatesh Munikrishnan, Akash Venkataramanan, Sudeepta Kumar Swain, Kaveripattu Sathiyamurthy Sunilkumar, Vadanika Venu, Muthuswamy Hariharan, Mohammad Zehran Saipillai, Asfar Ahamed   +8 more
doaj   +1 more source

Mismatch Repair–Deficient Rectal Cancer and Resistance to Neoadjuvant Chemotherapy

Clinical Cancer Research, 2020
Purpose: Evaluate response of mismatch repair–deficient (dMMR) rectal cancer to neoadjuvant chemotherapy. Experimental Design: dMMR rectal tumors at Memorial Sloan Kettering Cancer Center (New York, NY) were retrospectively reviewed for characteristics ...
A. Cercek, G. dos Santos Fernandes, C. Roxburgh, K. Ganesh, S. Ng, F. Sánchez-Vega, R. Yaeger, N. Segal, D. Reidy‐Lagunes, A. Varghese, A. Markowitz, Chao Wu, Bryan C Szeglin, Charles-Etienne Gabriel Sauvé, E. Salo-Mullen, Christina Tran, Z. Patel, Asha R Krishnan, K. Tkachuk, G. Nash, J. Guillem, P. Paty, J. Shia, N. Schultz, J. García-Aguilar, L. Diaz, K. Goodman, L. Saltz, M. Weiser, J. Smith, Z. Stadler   +30 more
semanticscholar   +1 more source

Phase II trial of preoperative radiochemotherapy with concurrent bevacizumab, capecitabine and oxaliplatin in patients with locally advanced rectal cancer [PDF]

, 2013
Background: Preoperative radiochemotherapy (RCT) with 5-FU or capecitabine is the standard of care for patients with locally advanced rectal cancer (LARC). Preoperative RCT achieves pathological complete response rates (pCR) of 10-15%.
Arnold, Dirk, Dellas, Kathrin, Dunst, Jürgen, Engel, Erik, Höhler, Thomas, Reese, Thomas, Richter, Michael, Rödel, Claus, Wagner, Wolfgang, Würschmidt, Florian   +9 more
core   +1 more source

An ileal gastrointestinal stromal tumor misdiagnosed as pelvic metastases from rectal cancer: a case report

Frontiers in Oncology, 2023
With the advancement of imaging and pathological diagnostic methods, it is not uncommon to see synchronous gastrointestinal stromal tumors (GIST) and other primary cancers, the most common of which are synchronous gastric cancer and gastric GIST. However,
Jun Ma, Juan Zhu, Shuihong Yu, Chaoping Zhou, Shuqiang Duan, Yaming Zhang   +5 more
doaj   +1 more source

Colon and rectal cancer survival in seven high-income countries 2010–2014: variation by age and stage at diagnosis (the ICBP SURVMARK-2 project)

Gut, 2020
Objectives As part of the International Cancer Benchmarking Partnership (ICBP) SURVMARK-2 project, we provide the most recent estimates of colon and rectal cancer survival in seven high-income countries by age and stage at diagnosis.
M. Araghi, M. Arnold, M. Rutherford, M. Guren, C. Cabasag, A. Bardot, J. Ferlay, H. Tervonen, L. Shack, R. Woods, N. Saint-Jacques, P. De, C. McClure, G. Engholm, A. Gavin, E. Morgan, P. Walsh, C. Jackson, G. Porter, B. Møller, O. Bucher, Michael Eden, D. O’Connell, F. Bray, I. Soerjomataram   +24 more
semanticscholar   +1 more source

Combination of radiotherapy and suppression of Tregs enhances abscopal antitumor effect and inhibits metastasis in rectal cancer

Journal for ImmunoTherapy of Cancer, 2020
Background Distant metastasis is the major cause of mortality in patients with locally advanced rectal cancer (LARC) following neoadjuvant chemoradiotherapy. Local radiotherapy can trigger an abscopal response to metastatic tumor cells.
D. Ji, Can Song, Yongheng Li, Jinhong Xia, Yanjing Wu, Jinying Jia, Xinxin Cui, Songmao Yu, J. Gu   +8 more
semanticscholar   +1 more source

Magnetic resonance tumor regression grade (MR-TRG) to assess pathological complete response following neoadjuvant radiochemotherapy in locally advanced rectal cancer [PDF]

, 2017
This study aims to evaluate the feasibility of a magnetic resonance (MR) automatic method for quantitative assessment of the percentage of fibrosis developed within locally advanced rectal cancers (LARC) after neoadjuvant radiochemotherapy (RCT). A total
Bellini, D, Caruso, D, Caterino, Martina, Ciolina, M, De Santis, D, Laghi, A., Marzi, S, Musio, Daniela, Picchia, S, Rengo, M, Tombolini, V   +10 more
core   +1 more source

Radio-chemotherapy as a preoperative treatment for advanced rectal cancer. Evaluation of down-staging and morbidity [PDF]

, 2002
Background: The standard therapy for patients with clinically resectable rectal cancer is generally considered to be surgery, If the patient is diagnosed with advanced disease, postoperative radiochemotherapy (RCT) is usually recommended. In our study we
Dühmke, Eckhart, Schaffer, Moshe, Schaffer, Pamela Manuela, Thoma, M., Wilkowski, R.   +4 more
core   +1 more source